These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6148592)

  • 1. Hepatitis B vaccination: how long does protection last?
    Laplanche A; Courouce AM; Jungers P; Benhamou E; Crosnier J
    Lancet; 1984 Oct; 2(8407):866. PubMed ID: 6148592
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B vaccine: responder status and timing of additional booster doses.
    Fagan EA; Williams R; Eddleston AL
    Lancet; 1987 Sep; 2(8558):561. PubMed ID: 2887842
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma-derived versus recombinant hepatitis B vaccines.
    Kurtz JB; Alder MJ; Mayon-White RT; Juel-Jensen BE; Rodgers TM; Babic GM
    Lancet; 1989 Feb; 1(8635):451. PubMed ID: 2563836
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal by intradermal hepatitis B vaccination of unresponsiveness to HBsAg.
    Nagafuchi S; Kashiwagi S
    Lancet; 1987 Dec; 2(8574):1522-3. PubMed ID: 2892077
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of HBV markers in the Italian Armed Forces and HBV vaccination.
    D'Amelio R; Matricardi PM; Nisini R; Le Moli S; Fattorossi A; Di Addario A; Castagliuolo PP
    Mil Med; 1989 Dec; 154(12):589-92. PubMed ID: 2532310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccination in newborn babies.
    Heijtink RA; Weber YA; Mazel JA
    Lancet; 1988 May; 1(8596):1226. PubMed ID: 2897038
    [No Abstract]   [Full Text] [Related]  

  • 7. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the immune response after the inoculation of hepatitis B vaccine--with special reference to evaluation by indirect hemagglutination].
    Takamiya H; Funato T; Ohtani H; Saito M
    Rinsho Byori; 1985 Dec; 33(12):1395-400. PubMed ID: 2937942
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B vaccination and idiopathic haemochromatosis.
    Saddi RS; Ebelin P; Pouliquen A; Gautreau C; Durand J; Jammet P; Courouce AM; Brechot C; Franco D; Thibult N
    Lancet; 1985 Nov; 2(8463):1061-2. PubMed ID: 2865532
    [No Abstract]   [Full Text] [Related]  

  • 10. [Limited value of anti-HBs determination following vaccination against hepatitis B].
    Heijtink RA
    Ned Tijdschr Geneeskd; 1987 Aug; 131(33):1443-4. PubMed ID: 2959868
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B immunisation.
    Segal GR
    Med J Aust; 1991 Jan; 154(1):70-1. PubMed ID: 1824604
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B vaccine in a hospital.
    Schaaff DM; Lender M; Snedeker P; Graham LA
    Ann Intern Med; 1984 Nov; 101(5):720-1. PubMed ID: 6237600
    [No Abstract]   [Full Text] [Related]  

  • 13. The immune response of low dose recombinant DNA hepatitis B vaccine in teenagers in Singapore.
    Guan R; Tay HH; Yap I; Smith R; Tan LH
    Trans R Soc Trop Med Hyg; 1990; 84(5):731-2. PubMed ID: 2148992
    [No Abstract]   [Full Text] [Related]  

  • 14. Mass vaccination against hepatitis B in preschool children: immunogenicity after three reduced doses.
    Milne A; Moyes CD; Waldon J; Pearce NE; Krugman S
    N Z Med J; 1989 Aug; 102(874):429-30. PubMed ID: 2527346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term immunogenicity of hepatitis B vaccine in the neonate and children at risk: antibody levels and indications for booster doses].
    Corbella E; Garghetti L; Poloniato A; Zambelloni C; Consonni A
    Minerva Pediatr; 1987 Oct; 39(20):821-6. PubMed ID: 2963953
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recombinant hepatitis B vaccine in health personnel. Immunogenicity of a rapid vaccination schedule].
    Cremades M; Bas J; Mayor A; Laguna P; Sanjosé L; Bruguera M
    Med Clin (Barc); 1989 Dec; 93(18):684-6. PubMed ID: 2532693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of perinatal transmission of hepatitis B virus: a comparison between the efficacy of passive and passive-active immunization in Korea.
    Chung WK; Yoo JY; Sun HS; Lee HY; Lee IJ; Kim SM; Prince AM
    J Infect Dis; 1985 Feb; 151(2):280-6. PubMed ID: 3155778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anamnestic response to hepatitis B vaccine.
    Fay OH; Tanno H; Perez V; Palazzi J
    Lancet; 1985 Mar; 1(8429):647. PubMed ID: 2857990
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B vaccine.
    Drug Ther Bull; 1985 Jul; 23(13):49-51. PubMed ID: 3160568
    [No Abstract]   [Full Text] [Related]  

  • 20. Impaired immunogenicity of hepatitis B vaccine in obese persons.
    Weber DJ; Rutala WA; Samsa GP; Bradshaw SE; Lemon SM
    N Engl J Med; 1986 May; 314(21):1393. PubMed ID: 2939347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.